Log in to save to my catalogue

A high-throughput, fully automated competition assay to evaluate SARS-CoV-2 neutralizing responses a...

A high-throughput, fully automated competition assay to evaluate SARS-CoV-2 neutralizing responses a...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1deb9dfa172c4ea088d48ecd837223e5

A high-throughput, fully automated competition assay to evaluate SARS-CoV-2 neutralizing responses and epitope specificity in clinical samples

About this item

Full title

A high-throughput, fully automated competition assay to evaluate SARS-CoV-2 neutralizing responses and epitope specificity in clinical samples

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2025-04, Vol.15 (1), p.11589-7, Article 11589

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Coronavirus disease-2019 (COVID-19) remains a critical global health concern. We developed a fully automated, high-throughput competition immunoassay to elucidate how epitope recognition on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike receptor-binding domain (RBD) correlates with neutralizing activity. Analysis of clinical...

Alternative Titles

Full title

A high-throughput, fully automated competition assay to evaluate SARS-CoV-2 neutralizing responses and epitope specificity in clinical samples

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1deb9dfa172c4ea088d48ecd837223e5

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1deb9dfa172c4ea088d48ecd837223e5

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-025-94317-2

How to access this item